HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
DHR
Danaher Corp
Healthcare Diagnostics & Research · District Of Columbia, USA · Reports in usd
Market Cap: $125.34B
Market Cap
$125.34B
Enterprise Val
$138.12B
P/E Ratio
33.98
P/B Ratio
2.37
Trailing PEG (1Y)
3.77
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Mar 27, 2026 · Q1 2026
Book Value$52.96B
Gross Margin60.34%
Profit Margin60.34%
Return on Equity7.06%
Return on Assets4.49%
Current Ratio1.87
Debt/Equity0.35
LT Debt/Equity0.33
Revenue Per Share8.42

Income Statement

Mar 27, 2026
Revenue$5.95B
Cost of Revenue$2.36B
Gross Profit$3.59B
R&D$387.0M
SG&A$1.86B
Operating Expenses$2.25B
Operating Income$1.34B
Interest Expense$63.0M
Tax Expense$206.0M
Net Income$1.03B
EPS (Basic)$1.45
EPS (Diluted)$1.45
EBIT$1.30B
EBITDA$1.93B
Consolidated Income$1.03B
Non-Controlling Interests$0.00

Balance Sheet

Mar 27, 2026
Cash & Equivalents$5.70B
Accounts Receivable$3.82B
Inventory$2.61B
Current Assets$13.94B
LT Investments$0.00
Property, Plant & Equipment$5.47B
Intangibles$59.93B
Non-Current Assets$69.61B
Total Assets$83.54B
Accounts Payable$1.79B
Current Debt$923.0M
Current Liabilities$7.46B
LT Debt$17.56B
Non-Current Liabilities$23.13B
Total Liabilities$30.59B
Total Debt$18.48B
Retained Earnings$47.64B
Shareholder Equity$52.95B
Shares Outstanding707,139,356

Cash Flow Statement

Mar 27, 2026
Operating Cash Flow$1.32B
Investing Cash Flow-$249.0M
Financing Cash Flow$46.0M
CapEx-$237.0M
Free Cash Flow$1.09B
Depreciation & Amort.$627.0M
Stock-Based Comp$58.0M
Acquisitions / Disposals$0.00
Investment Activity-$20.0M
Debt Issued/Repaid$309.0M
Equity Issued/Repaid-$9.0M
Dividends Paid-$226.0M
Net Change in Cash$1.09B
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h